New program aims to help pregnant women with opioid addiction and their babies

NCT ID NCT05609669

Ongoing Disease control Sponsor: University of South Florida Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a program that connects pregnant women with opioid use disorder to a team of doctors, peer supporters, and community resources like doulas and home visiting. The goal is to improve treatment during pregnancy and reduce the need for medication in newborns experiencing withdrawal. Only 10 participants are enrolled, so this is an early test of the program's feasibility.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Integrated care program (peer support, care navigation, community resources)
What this could lead to: If successful, this could show that coordinated care helps more mothers stay on treatment and reduces the need for medication in newborns with withdrawal.
What could go wrong: This is a very small pilot study (10 participants) with no control group, so results may not be generalizable. The program's success depends on community resources that may not be available elsewhere.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OPIOID-USE DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

opiate dependence pregnancy disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

OPIOID-USE DISORDER PREGNANCY RELATED

Contacts and locations

Locations

University of South Florida/Tampa General Hospital

Tampa, Florida, 33606, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.